ConductScience.org, home

Paper21765641

Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.

Lu B and 5 others. J Biomed Biotechnol, 2011. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain. Papers, record 21765641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21765641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
PubMed
Journal
J Biomed Biotechnol
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2024-04-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu BBin
2Yu WWenbo
3Huang XXiaoxing
4Wang HHaibo
5Liu LLi
6Chen ZZhiwei

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, NeutralizingMajor topic
Immunity, MucosalMajor topic
Smallpox VaccineMajor topic
VacciniaMajor topic
Vaccinia virusMajor topic
Administration, Intranasal
Administration, Oral
Animals
Antibodies, Viral
Female
Immunization
Injections, Intramuscular
Injections, Subcutaneous
Mice
Mice, Inbred BALB C
Smallpox
Vaccination
Vaccines, Attenuated
Variola virus

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120045097One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.Vaccine2010https://conductscience.org/library/papers/20045097PubMed
2788150The eradication of smallpox.Sci Am1976https://conductscience.org/library/papers/788150PubMed
310200293Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10200293PubMed
416759767Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.Vaccine2006https://conductscience.org/library/papers/16759767PubMed
521994611The development of an AIDS mucosal vaccine.Viruses2010https://conductscience.org/library/papers/21994611PubMed
610229229Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.Nat Med1999https://conductscience.org/library/papers/10229229PubMed
718093703
Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
Vaccine2008https://conductscience.org/library/papers/18093703PubMed
819159014A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.PLoS One2009https://conductscience.org/library/papers/19159014PubMed
918234801Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.J Virol2008https://conductscience.org/library/papers/18234801PubMed
1017581748Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.Appl Microbiol Biotechnol2007https://conductscience.org/library/papers/17581748PubMed
1112201305Responses to smallpox vaccine.N Engl J Med2002https://conductscience.org/library/papers/12201305PubMed
1218398296Protective immunity following vaccination: how is it defined?Hum Vaccin2008https://conductscience.org/library/papers/18398296PubMed
1312970455Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.J Virol2003https://conductscience.org/library/papers/12970455PubMed
1412856218Smallpox vaccination: a review, part II. Adverse events.Clin Infect Dis2003https://conductscience.org/library/papers/12856218PubMed
1515708987
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.
J Virol2005https://conductscience.org/library/papers/15708987PubMed
1615951823Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.Nat Med2005https://conductscience.org/library/papers/15951823PubMed
1716168312Smallpox.Crit Care Clin2005https://conductscience.org/library/papers/16168312PubMed
1819500964Heterologous prime-boost vaccination.Curr Opin Immunol2009https://conductscience.org/library/papers/19500964PubMed
1917529982Lymphoid reservoirs of antigen-specific memory T helper cells.Nat Immunol2007https://conductscience.org/library/papers/17529982PubMed
2018061316Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.Vaccine2007https://conductscience.org/library/papers/18061316PubMed

See all 39 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41589837Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model.J Virol2026https://conductscience.org/library/papers/41589837PubMed
37822719A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.Mol Ther Methods Clin Dev2023https://conductscience.org/library/papers/37822719PubMed
35935962Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate.Front Immunol2022https://conductscience.org/library/papers/35935962PubMed
34687845Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.Mol Ther2022https://conductscience.org/library/papers/34687845PubMed
32698399IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model.Vaccines (Basel)2020https://conductscience.org/library/papers/32698399PubMed
24050999Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.Virus Res2013https://conductscience.org/library/papers/24050999PubMed
23994378The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.Vaccine2013https://conductscience.org/library/papers/23994378PubMed
23593246Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.PLoS One2013https://conductscience.org/library/papers/23593246PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21765641

GET https://conductscience.org/api/papers/v1/21765641/references?page=2